Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer : can we rely on large randomized control trials in the era of personalized medicine?
Long-term toxic effects of adjuvant chemotherapy in breast cancer
Novel approaches and future directions in castration-resistant prostate cancer
Alcohol drinking and colorectal cancer risk : an overall and dose–response meta-analysis of published studies
1st ESMO Consensus Conference in lung cancer; Lugano 2010 : Small-cell lung cancer
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors : Long-term follow up on IBCSG Trial IX
PREPARE trial : a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer—results at the time of surgery
PREPARE trial : a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin–cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer—outcome on prognosis
Very high quantitative tumor HER2 content and outcome in early breast cancer
Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab
Additional value and potential use of the 70-gene prognosis signature in node-negative breast cancer in daily clinical practice
Response to influenza virus vaccination during chemotherapy in patients with breast cancer
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer
A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection
Tumor–ratio–metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection—results of a single-institution study of 1343 Chinese patients
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer
Significance of smoking history and FDG uptake for pathological N2 staging in clinical N2-negative non-small-cell lung cancer
Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients : results of a randomized, double-blind, placebo-controlled pilot trial
Impact of neutropenia on the outcomes of critically ill patients with cancer : a matched case–control study
Incidental versus symptomatic venous thrombosis in cancer : a prospective observational study of 340 consecutive patients
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients
Late referrals to home palliative care service affecting death at home in advanced cancer patients in Japan : a nationwide survey
Usefulness of a bidirectional e-learning material for explaining surgical anesthesia to cancer patients
Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer : a prospective cohort study
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
Circulating cancer cells in division in an early breast cancer patient
Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy
Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysis